Literature DB >> 28760993

Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation.

Zhao Zha1, Felicitas Bucher2, Anahita Nejatfard1, Tianqing Zheng1, Hongkai Zhang1, Kyungmoo Yea3, Richard A Lerner3.   

Abstract

Cytokines are protein mediators that are known to be involved in many biological processes, including cell growth, survival, inflammation, and development. To study their regulation, we generated a library of 209 different cytokines. This was used in a combinatorial format to study the effects of cytokines on each other, with particular reference to the control of differentiation. This study showed that IFN-γ is a master checkpoint regulator for many cytokines. It operates via an autocrine mechanism to elevate STAT1 and induce internalization of gp130, a common component of many heterodimeric cytokine receptors. This targeting of a receptor subunit that is common to all members of an otherwise diverse family solves the problem of how a master regulator can control so many diverse receptors. When one adds an autocrine mechanism, fine control at the level of individual cells is achieved.

Entities:  

Keywords:  checkpoint; cytokine; differentiation; interferon-γ; master regulator

Mesh:

Substances:

Year:  2017        PMID: 28760993      PMCID: PMC5565454          DOI: 10.1073/pnas.1706915114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.

Authors:  S Gronthos; M Mankani; J Brahim; P G Robey; S Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways.

Authors:  Thomas Meyer; Andreas Begitt; Inga Lödige; Marleen van Rossum; Uwe Vinkemeier
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

Review 4.  Integration of cytokine and heterologous receptor signaling pathways.

Authors:  Jelena S Bezbradica; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 5.  Genetic control of bone formation.

Authors:  Gerard Karsenty; Henry M Kronenberg; Carmine Settembre
Journal:  Annu Rev Cell Dev Biol       Date:  2009       Impact factor: 13.827

6.  Autocrine signaling based selection of combinatorial antibodies that transdifferentiate human stem cells.

Authors:  Jia Xie; Hongkai Zhang; Kyungmoo Yea; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

7.  Phosphorylation of human gp130 at Ser-782 adjacent to the Di-leucine internalization motif. Effects on expression and signaling.

Authors:  R M Gibson; W P Schiemann; L B Prichard; J M Reno; L H Ericsson; N M Nathanson
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

Review 8.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

Review 9.  STAT proteins: from normal control of cellular events to tumorigenesis.

Authors:  Valentina Calò; Manuela Migliavacca; Viviana Bazan; Marcella Macaluso; Maria Buscemi; Nicola Gebbia; Antonio Russo
Journal:  J Cell Physiol       Date:  2003-11       Impact factor: 6.384

10.  Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis.

Authors:  Gustavo Duque; Dao Chao Huang; Michael Macoritto; Daniel Rivas; Xian Fang Yang; Louis Georges Ste-Marie; Richard Kremer
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

View more
  16 in total

Review 1.  Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways.

Authors:  Xue Bai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

2.  Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Authors:  Dipankar Ray; Paramita Ray; Daysha Ferrer-Torres; Zhuwen Wang; Derek Nancarrow; Hee-Won Yoon; May San Martinho; Tonaye Hinton; Scott Owens; Dafydd Thomas; Hui Jiang; Theodore S Lawrence; Jules Lin; Kiran Lagisetty; Andrew C Chang; David G Beer
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

3.  Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-γ-induced contractile deficit in engineered human myocardium.

Authors:  Ren-Zhi Zhan; Lingjun Rao; Zhaowei Chen; Nicholas Strash; Nenad Bursac
Journal:  Acta Biomater       Date:  2021-03-08       Impact factor: 8.947

4.  A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3.

Authors:  Sara Ibrahim; Arianna Harris-Kawano; Isra Haider; Raghavendra G Mirmira; Emily K Sims; Ryan M Anderson
Journal:  Dis Model Mech       Date:  2020-06-26       Impact factor: 5.758

5.  Effect of Intermittent and Mild Cold Stimulation on the Immune Function of Bursa in Broilers.

Authors:  Yanhong Liu; Ge Xue; Shuang Li; Yajie Fu; Jingwen Yin; Runxiang Zhang; Jianhong Li
Journal:  Animals (Basel)       Date:  2020-07-26       Impact factor: 2.752

6.  PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.

Authors:  Xian-De Liu; Wen Kong; Christine B Peterson; Daniel J McGrail; Anh Hoang; Xuesong Zhang; Truong Lam; Patrick G Pilie; Haifeng Zhu; Kathryn E Beckermann; Scott M Haake; Sevinj Isgandrova; Margarita Martinez-Moczygemba; Nidhi Sahni; Nizar M Tannir; Shiaw-Yih Lin; W Kimryn Rathmell; Eric Jonasch
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

Review 7.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

8.  Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

Authors:  Niki Karachaliou; Maria Gonzalez-Cao; Guillermo Crespo; Ana Drozdowskyj; Erika Aldeguer; Ana Gimenez-Capitan; Cristina Teixido; Miguel Angel Molina-Vila; Santiago Viteri; Maria De Los Llanos Gil; Salvador Martin Algarra; Elisabeth Perez-Ruiz; Ivan Marquez-Rodas; Delvys Rodriguez-Abreu; Remedios Blanco; Teresa Puertolas; Maria Angeles Royo; Rafael Rosell
Journal:  Ther Adv Med Oncol       Date:  2018-01-18       Impact factor: 8.168

Review 9.  The Dual Nature of Type I and Type II Interferons.

Authors:  Amanda J Lee; Ali A Ashkar
Journal:  Front Immunol       Date:  2018-09-11       Impact factor: 7.561

10.  Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting.

Authors:  Aileen L Rowland; Donald Miller; Alix Berglund; Lauren V Schnabel; Gwendolyn J Levine; Douglas F Antczak; Ashlee E Watts
Journal:  Stem Cells Transl Med       Date:  2020-12-25       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.